377 results on '"Lucianò, Roberta"'
Search Results
2. Pulmonary lesion after surgery for renal cancer: progression or new primary?
3. Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis
4. Progressive alteration of murine bladder elasticity in actinic cystitis detected by Brillouin microscopy
5. SIUrO best practice recommendations to optimize BRCA 1/2 gene testing from DNA extracted from bone biopsy in mCRPC patients (BRCA Optimal Bone Biopsy Procedure: BOP)
6. Topographic modification of the extracellular matrix precedes the onset of bladder cancer
7. Role of Follicle-stimulating Hormone, Inhibin B, and Anti-Müllerian Hormone in Predicting Sperm Retrieval from Men with Nonobstructive Azoospermia Undergoing Microdissection Testicular Sperm Extraction: A Systematic Review and Meta-analysis
8. A simple and robust nanosystem for photoacoustic imaging of bladder cancer based on α5β1-targeted gold nanorods
9. Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression
10. Pathologic Features of Response to Neoadjuvant Therapies in Muscle-Invasive Bladder Cancer: More than Meets the Eye
11. Effectiveness and Safety of Thulium Fiber Laser in the Conservative Management of Patients with Upper Tract Urothelial Carcinoma
12. Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods
13. Mitomycin C vs. Bacillus Calmette–Guerin for treatment of intermediate-risk nonmuscle invasive bladder cancer patients—A comparative analysis from a single center
14. Gold nanorod-assisted theranostic solution for nonvisible residual disease in bladder cancer.
15. Testicular Germ-Cell Tumors with Spermatic Cord Involvement: A Retrospective International Multi-Institutional Experience
16. Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer
17. MP51-03 PREOPERATIVE OR INTRAOPERATIVE RENAL BIOPSY INCREASES THE ACCURACY IN PREDICTING LYMPH NODE INVASION IN PATIENTS WITH RENAL CELL CARCINOMA
18. MP77-11 NOMOGRAM PREDICTING OPTIMAL CANDIDATES FOR BLADDER-SPARING STRATEGIES AFTER NEOADJUVANT IMMUNOTHERAPY
19. MP71-15 CANCER CONTROL RATES IN ADEQUATE VERSUS INADEQUATE TREATMENT WITH ADJUVANT IMMUNOTHERAPY INSTILLATIONS WITH BCG
20. MP71-07 THE IMPACT OF CENTRALIZED UROPATHOLOGY REVIEW IN THE MANAGEMENT OF BLADDER CANCER PATIENTS AT THE TIME OF TRANSURETHRAL RESECTION OF THE BLADDER
21. MP16-11 LONG-TERM OUTCOMES OF PTA HIGH GRADE INTERMEDIATE AND HIGH RISK BLADDER CANCER PATIENTS
22. PD09-03 ASSESSING EPIGENETIC FEATURES ASSOCIATED WITH LYMPH NODE METASTASES IN PROSTATE CANCER
23. MP53-18 IMPACT OF NEOADJUVANT CHEMO-IMMUNOTHERAPY ON INTRA AND POST OPERATIVE OUTCOMES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY AND PELVIC LYMPH NODE DISSECTION: PROSPECTIVE SURGICAL ASSESSMENT FROM THE NURE-COMBO TRIAL
24. MP53-02 RISK OF NODE METASTASES IN MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMO- OR IMMUNOTHERAPY AND RADICAL CYSTECTOMY WITH BILATERAL PELVIC LYMPH NODE DISSECTION
25. MP36-14 HOW TO PERFORM THE OPTIMAL RENAL BIOPSY: A MACHINE LEARNING-BASED INDICATION
26. PD38-03 DETECTION OF LYMPH NODE INVOLVEMENT BEFORE RADICAL CYSTECTOMY: DIAGNOSTIC PERFORMANCE OF 18F-FDG PET/CT AND IMPLICATIONS IN THE THERAPEUTIC MANAGEMENT
27. MP44-03 THE IMPACT OF ISCHEMIA TIME ON RENAL FUNCTION IN PATIENTS WITH MICROCIRCULATION IMPAIRMENT DURING PARTIAL NEPHRECTOMY FOR RCC
28. PD30-01 DEFINING INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER: A COMPARATIVE STUDY OF EAU AND IBCG CRITERIA
29. PD61-04 LONG-TERM ONCOLOGICAL OUTCOMES OF SURGICALLY MANAGED VERY HIGH-RISK PROSTATE CANCER PATIENTS ACCORDING TO THE STAMPEDE TRIAL DEFINITION: IMPLICATIONS FOR THE SELECTION OF CANDIDATES FOR CLINICAL TRIALS
30. Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review
31. Renal histology across the stages of chronic kidney disease
32. Contrast enhanced photoacoustic detection of fibrillar collagen in the near infrared region-I.
33. Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study
34. The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial
35. Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes
36. Aberrant expression of GATA3 in metastatic adenocarcinoma of the prostate: an important pitfall
37. Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer
38. Cystic Clear Cell Renal Cell Carcinoma: A Morphological and Molecular Reappraisal
39. Anti-Müllerian hormone predicts positive sperm retrieval in men with idiopathic non-obstructive azoospermia—findings from a multi-centric cross-sectional study
40. Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients
41. Aberrant expression of GATA3 in metastatic adenocarcinoma of the prostate: an important pitfall.
42. IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
43. PD10-09 A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION
44. MP58-12 VENOUS TUMOUR THROMBUS IN RENAL CELL CARCINOMA: LOCALLY ADVANCED OR METASTATIC DISEASE?
45. Data from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial
46. MP64-08 99m TC- SESTAMIBI SPECT/CT FOR THE CHARACTERIZATION OF SMALL RENAL MASSES: INITIAL EXPERIENCE FROM a TERTIARY REFERRAL CENTER
47. Supplementary Table S3 from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial
48. MP58-08 CONCORDANCE OF RENAL SINUS OR CALYCES INVASION BETWEEN PREOPERATIVE IMAGING AND FINAL PATHOLOGY AFTER SURGERY FOR KIDNEY CANCER
49. MP58-13 FUNCTIONAL OUTCOMES AFTER SURGERY IN PATIENTS WITH RENAL CANCER AND TUMOR THROMBUS
50. Supplementary Figures S1-S4 from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.